These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38293450)

  • 1. Physicochemical and pharmacotechnical characterization of Prussian blue for future Prussian blue oral dosage forms formulation.
    Martínez-Alonso B; Torres Pabón NS; Fernández-Bachiller MI; Durán GT; Crespo RG; Torrado-Salmerón CF; Sánchez AJ; Peña Fernández MÁ
    Heliyon; 2024 Jan; 10(2):e24284. PubMed ID: 38293450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of cesium binding to ferric hexacyanoferrate: Prussian blue.
    Faustino PJ; Yang Y; Progar JJ; Brownell CR; Sadrieh N; May JC; Leutzinger E; Place DA; Duffy EP; Houn F; Loewke SA; Mecozzi VJ; Ellison CD; Khan MA; Hussain AS; Lyon RC
    J Pharm Biomed Anal; 2008 May; 47(1):114-25. PubMed ID: 18242038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, Characterization, and
    Sandal N; Mittal G; Bhatnagar A; Pathak DP; Singh AK
    J Drug Deliv; 2017; 2017():4875784. PubMed ID: 29318045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral formulation of Prussian blue with improved efficacy for prophylactic use against thallium.
    Sandal N; Kumar V; Sharma P; Yadav M
    Drug Dev Ind Pharm; 2023 Feb; 49(2):149-158. PubMed ID: 36912805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of the thallium binding of soluble and insoluble Prussian blue hexacyanoferrate analogs: A scientific comparison based on their critical quality attributes.
    Faustino PJ; Brown A; Lowry B; Yang Y; Wang Y; Khan MA; Dunbar KR; Mohammad A
    Int J Pharm; 2019 Oct; 569():118600. PubMed ID: 31401298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination of thallium binding to ferric hexacyanoferrate: Prussian blue.
    Yang Y; Faustino PJ; Progar JJ; Brownell CR; Sadrieh N; May JC; Leutzinger E; Place DA; Duffy EP; Yu LX; Khan MA; Lyon RC
    Int J Pharm; 2008 Apr; 353(1-2):187-94. PubMed ID: 18226478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic, equilibrium and human studies of adsorption of 201Tl by Prussian blue.
    Bhardwaj N; Bhatnagar A; Pathak DP; Singh AK
    Health Phys; 2006 Mar; 90(3):250-7. PubMed ID: 16505622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient removal of Cs(I) from water using a novel Prussian blue and graphene oxide modified PVDF membrane: Preparation, characterization, and mechanism.
    Zhang Y; Wang H; Gao K; Huang D; Hou L; Yang Y
    Sci Total Environ; 2022 Sep; 838(Pt 4):156530. PubMed ID: 35679934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in development and management of orphan drugs-a case study of Prussian blue insoluble.
    Sandal N
    J Radiol Prot; 2023 Oct; 43(4):. PubMed ID: 37816335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-dependent Release Matrix Oral Formulation of Prussian Blue to Improve its Efficacy as an Internal Decorporation Agent.
    Agrawal V; Sandal N; Singh AK; Pathak DP
    Curr Drug Deliv; 2021; 18(8):1162-1173. PubMed ID: 33504305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Prussian blue analog as a decorporation agent for the simultaneous removal of cesium and reactive oxygen species.
    Xue T; Liu F; Lu B; Dong Q; Zhao B; Chen T; Zhang K; Li J; Du J
    Nanoscale Adv; 2023 Oct; 5(20):5661-5670. PubMed ID: 37822904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term stability study of Prussian blue-A quality assessment of water content and cyanide release.
    Mohammad A; Yang Y; Khan MA; Faustino PJ
    Clin Toxicol (Phila); 2015 Feb; 53(2):102-7. PubMed ID: 25608705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long-term stability study of Prussian blue: A quality assessment of water content and cesium binding.
    Mohammad A; Yang Y; Khan MA; Faustino PJ
    J Pharm Biomed Anal; 2015 Jan; 103():85-90. PubMed ID: 25462125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of cesium and strontium for radioactive wastewater by Prussian blue nanorods.
    Yao C; Dai Y; Chang S; Zhang H
    Environ Sci Pollut Res Int; 2023 Mar; 30(13):36807-36823. PubMed ID: 36564688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble or insoluble prussian blue for radiocesium and thallium poisoning?
    Thompson DF; Callen ED
    Ann Pharmacother; 2004 Sep; 38(9):1509-14. PubMed ID: 15252192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of inclusion of thallium-201 into Prussian blue nanoparticles for nuclear medicine applications.
    Wulfmeier KM; Blower PJ; Fajardo GP; Huband S; de Rosales RTM; Walker D; Terry SY; Abbate V; Pellico J
    J Mater Chem B; 2024 Jul; ():. PubMed ID: 39007256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term stability study of Prussian blue - a quality assessment of water content and thallium binding.
    Mohammad A; Faustino PJ; Khan MA; Yang Y
    Int J Pharm; 2014 Dec; 477(1-2):122-7. PubMed ID: 25311178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro cyanide release of four prussian blue salts used for the treatment of cesium contaminated persons.
    Verzijl JM; Joore HC; van Dijk A; Wierckx FC; Savelkoul TJ; Glerum JH
    J Toxicol Clin Toxicol; 1993; 31(4):553-62. PubMed ID: 8254697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between physicochemical properties of prussian blue and its efficacy as antidote against thallium poisoning.
    Kravzov J; Rios C; Altagracia M; Monroy-Noyola A; López F
    J Appl Toxicol; 1993; 13(3):213-6. PubMed ID: 8326092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Prussian blue and N-acetylcysteine on thallium toxicity in mice.
    Meggs WJ; Cahill-Morasco R; Shih RD; Goldfrank LR; Hoffman RS
    J Toxicol Clin Toxicol; 1997; 35(2):163-6. PubMed ID: 9120885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.